Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff et al. · Journal of Clinical Oncology · 2009 · 670 citations

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

Iskra Pusic, Shi Yuan Jiang, Scott Landua et al. · Biology of Blood and Marrow Transplantation · 2008 · 348 citations · Full text

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Steven M. Devine, Ravi Vij, Michael P. Rettig et al. · Blood · 2008 · 306 citations · Full text

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Stefan Früehauf, Marlon R. Veldwijk, Timon Seeger et al. · Cytotherapy · 2009 · 123 citations

Inflammation, Plerixafor Mobilizes, Granulocyte +10

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures

Robert E. Donahue, Ping Jin, Aylin Bonifacino et al. · Blood · 2009 · 108 citations · Full text